SUN PHARMACEUTICAL INDUSTRIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,531 INR | -0.32% |
|
+2.46% | +21.59% |
| 05-09 | India's Alembic Pharma posts higher Q4 profit on strong N.America sales | RE |
| 05-08 | Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner Secunderabad, Telangana | CI |
Presenter SpeechAnoop Deshpande (Executives)Good afternoon, everybody. Myself, Anoop Deshpande...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows:
- generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment;
- other (6%) : primarily active pharmaceutical ingredients.
At the end of March 2021, the group had 44 production plants worldwide.
Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Sector
Pharmaceuticals
Calendar
21/05/2024
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
1,531
INR
Average target price
1,575
INR
Spread / Average Target
+2.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.59% | 44.15B | |
| +23.03% | 23.02B | |
| +18.22% | 15.33B | |
| +12.26% | 13.74B | |
| +52.55% | 12.16B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.66B | |
| +7.89% | 4.85B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Transcript : Sun Pharmaceutical Industries Limited - Shareholder/Analyst Call
